Dengue virus found in sperm? tiny study investigates
NCT ID NCT03612609
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study looked for dengue virus in the sperm of 10 men with active dengue infection. Researchers collected semen, urine, and blood samples over 90 days to see if the virus is present and where it hides. The goal is to understand if the virus can be in sperm and whether standard sperm processing can remove it, which could help guide safety advice for men recovering from dengue.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors give better advice to men recovering from dengue about risks of sexual transmission and safety during fertility treatments.
- What could go wrong
- This is a very small pilot study with only 10 men, so findings may not apply to everyone. It only looks for the virus in sperm, not whether it can actually spread through sex.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
10 people
The number who actually took part.
- Started
-
Feb 2019
- Finished
-
Aug 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient male aged 18 to 45 years * Patient in acute phase of dengue virus infection and with clinical criteria (date of onset of known clinical signs) which if thet aren't specific can be highly evocative in an epidemic zone. For example: Fever, asthenia, rash, arthritis/arthralgia, myalgia, headache, conjunctivitis. * Detection of the dengue virus genome by reverse transcriptase polymerase chain reaction in the blood or urine * Patient who can move to the laboratory for samples * Patient having given his free and informed consent and having signed the consent * Patient affiliated with a social security scheme or equivalent Exclusion Criteria: * Patient with an ejaculation disorder or who cannot sperm collection or with a sperm volume abnormal (\<1,5 ml). * Patient under guardianship or under trusteeship * Patient already included in a research protocol
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dengue are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Saint-Pierre
Saint-Pierre, 97448, Reunion
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dengue vaccine takes on a controlled virus challenge
- Why does dengue put some people in the hospital? scientists track 258 patients to find out
- Can a digital assistant and quick tests stop unnecessary antibiotics for kids?
- Can a digital assistant help clinics catch dengue fever faster?
- Can detailed tracking of dengue patients sharpen the next generation of clinical trials?
- Scientists deliberately infect volunteers with dengue to unlock immune secrets